Bilimsel Makale Arama | NeuralCipher AI

Açık erişim

Initiating levodopa pump therapy: a qualitative study of patient and caregiver perspectives.

Scharfenort M, Nobrell A, Garon M, Rosqvist K, Paul G, Nilsson MH, Antonini A, Nyholm D, Odin P, Mangrio E.

BMC Nurs · 2026-10-20

DOI: 10.1186/s12912-026-05527-6PMID: 42908002

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A critical mechanistic synthesis of PINK1-mediated mitophagy signaling and its therapeutic targeting in Parkinson's disease neurodegeneration.

Khan A, Jawaid T, Rehman ZU, Alshammari MK, Bakht MA, Shakeel F, Zawiah M, Imran M.

Exp Neurol · 2026-10-18

DOI: 10.1016/j.expneurol.2026.116078PMID: 42893778

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Modulating neuroinflammation with glucagon-like peptide-1 receptor agonists: a scoping review exploring their therapeutic potential in schizophrenia.

Otto B, Zantvoord JB, Siskind D, Vermeulen JM.

Prog Neuropsychopharmacol Biol Psychiatry · 2026-10-17

DOI: 10.1016/j.pnpbp.2026.111978PMID: 42887669

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Restoring Neural Homeostasis via Class II HDAC Modulation: Mechanistic Insights and Therapeutic Opportunities.

Gupta R, Kumar R, K S BS, Modi DK, Kumari S, Kumar N, Singh P, Ravi K, Abomughaid MM.

Mol Neurobiol · 2026-10-15

DOI: 10.1007/s12035-026-06265-1PMID: 42875680

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A novel UPLC-ECD method for simultaneous quantification of levodopa, benserazide, and their major metabolites in human plasma and cerebrospinal fluid.

Lu S, Qiu Y, Ma S, Huang Q, Li M, Wu L.

J Pharm Biomed Anal · 2026-10-14

DOI: 10.1016/j.jpba.2026.117770PMID: 42906213

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Conformational allocation of mitofusin 2 in neuronal mitochondrial dynamics: Mechanisms and therapeutic targeting.

Zhang ZY, Qin BQ, Wu SZ, Zhang H.

Biochem Pharmacol · 2026-10-13

DOI: 10.1016/j.bcp.2026.118545PMID: 42869255

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Targeting Nrf2 signaling in Parkinson's disease: Mechanisms, strategies, and therapeutic perspectives.

Cao Y, Zhang J, Peng S.

Free Radic Biol Med · 2026-10-13

DOI: 10.1016/j.freeradbiomed.2026.10.027PMID: 42869304

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Towards a Better Definition of Patient-Centered Therapeutic Strategy of Parkinson's Disease: An Opinion Paper.

Reichmann H, Antonini A, Chaudhuri KR, Danaila T, Devos D, Foltynie T, Jesús Maestre S, Jost WH, Kaasinen V, Katzenschlager R, López Manzanares L, Pagonabarraga Mora J, Santens P, Santos García D, Tamburin S, Winkler J, Rascol O.

Neurol Ther · 2026-10-13

DOI: 10.1007/s40120-026-01055-2PMID: 42870196

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

From Hypothesis to Clinical Validation: A Bibliometric Mapping of Immunotherapy for Neurodegenerative Proteinopathies (2000-2025).

Budak Savaş A, Yeşilyurt F, Hacimuftuoglu A.

CNS Neurol Disord Drug Targets · 2026-10-13

DOI: 10.2174/0118715273531307261012100737PMID: 42872646

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Targeting the Gut to Modify Parkinson's Disease: From Mechanisms to Potential Therapeutics.

Tai YC, Lin CH.

J Mov Disord · 2026-10-12

DOI: 10.14802/jmd.26285PMID: 42860646

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Persistent Therapeutic Burden after Device-Aided Therapy in Parkinson's Disease: Insights from Post-DAT MANAGE-PD Assessment.

Onder H, Gültekin M, Yavuz Z, Çıplaklıgil A, Comoglu S.

Mov Disord Clin Pract · 2026-10-12

DOI: 10.1002/mdc3.70861PMID: 42860929

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Diagnostic approach and treatment options for myoclonus.

Suratos CT, Pascual JM, Ng A, Teleg R, Fung VSC.

J Neural Transm (Vienna) · 2026-10-12

DOI: 10.1007/s00702-026-03303-zPMID: 42862330

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

10.361 makale bulundu

Initiating levodopa pump therapy: a qualitative study of patient and caregiver perspectives.

A critical mechanistic synthesis of PINK1-mediated mitophagy signaling and its therapeutic targeting in Parkinson's disease neurodegeneration.

Modulating neuroinflammation with glucagon-like peptide-1 receptor agonists: a scoping review exploring their therapeutic potential in schizophrenia.

Restoring Neural Homeostasis via Class II HDAC Modulation: Mechanistic Insights and Therapeutic Opportunities.

A novel UPLC-ECD method for simultaneous quantification of levodopa, benserazide, and their major metabolites in human plasma and cerebrospinal fluid.

Conformational allocation of mitofusin 2 in neuronal mitochondrial dynamics: Mechanisms and therapeutic targeting.

Targeting Nrf2 signaling in Parkinson's disease: Mechanisms, strategies, and therapeutic perspectives.

Towards a Better Definition of Patient-Centered Therapeutic Strategy of Parkinson's Disease: An Opinion Paper.

From Hypothesis to Clinical Validation: A Bibliometric Mapping of Immunotherapy for Neurodegenerative Proteinopathies (2000-2025).

Targeting the Gut to Modify Parkinson's Disease: From Mechanisms to Potential Therapeutics.

Persistent Therapeutic Burden after Device-Aided Therapy in Parkinson's Disease: Insights from Post-DAT MANAGE-PD Assessment.

Diagnostic approach and treatment options for myoclonus.

Filtreler